Clinical Trial Update: A Study to Test How BI 690517 is Taken up in the Body of People With and Without Liver Problems [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study assessing how BI 690517 is absorbed and processed in adults with liver impairment compared to healthy individuals; the study has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• BI 690517

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Liver Diseases, Healthy | Phase 1 | Status: COMPLETED